Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Hyperfine, Inc. reported the nine months ended September 30, 2023 results: revenue $8.35 million, net income $33.55 million, EPS $0.47 per share.
- Period
- the nine months ended September 30, 2023
- Revenue
- $8.35 million
- Net income
- $33.55 million
- EPS
- $0.47 per share
- Result
- reported results
Exact text from the filing
Revenues for the nine months ended September 30, 2023 were $8.35 million, compared to $5.39 million in the nine months ended September 30, 2022.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Hyperfine, Inc. reported the third quarter ended September 30, 2023 results: revenue $2.33 million, net income $10.76 million, EPS $0.15 per share.
- Period
- the third quarter ended September 30, 2023
- Revenue
- $2.33 million
- Net income
- $10.76 million
- EPS
- $0.15 per share
- Result
- reported results
Exact text from the filing
progress on all our clinical programs, including our upcoming Alzheimer’s feasibility study.” Third Quarter 2023 Financial Results • Revenues for the third quarter of 2023 were $2.33 million, compared to $2.35 million in the third quarter of 2022. • Hyperfine, Inc. sold six commercial Swoop® systems in the third quarter of 2023. • Gross margin for the third quarter
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Hyperfine, Inc. reported the full year 2023 results: revenue $11 to $13 million. Guidance initiated.
- Period
- the full year 2023
- Revenue
- $11 to $13 million
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Management expects revenue for the full year 2023 to be $11 to $13 million.
View on SEC.gov